We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+7.56%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$40.8B
AUM Growth
+$3.42B
(+9.2%)
Cap. Flow
+$1.07B
Cap. Flow
% of AUM
2.63%
Top 10 Holdings %
Top 10 Hldgs %
25.28%
Holding
2,151
New
303
Increased
1,108
Reduced
653
Closed
86
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
West Pharmaceutical
WST
|
+$197M |
| 2 |
Walmart Inc
WMT
|
+$193M |
| 3 |
NextEra Energy
NEE
|
+$177M |
| 4 |
Apple
AAPL
|
+$129M |
| 5 |
UnitedHealth
UNH
|
+$120M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$230M |
| 2 |
Sysco
SYY
|
+$164M |
| 3 |
Synopsys
SNPS
|
+$81.2M |
| 4 |
C.H. Robinson
CHRW
|
+$53.8M |
| 5 |
United Bankshares
UBSI
|
+$41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.01% |
| 2 | Consumer Staples | 11.62% |
| 3 | Industrials | 10.88% |
| 4 | Consumer Discretionary | 9.53% |
| 5 | Healthcare | 9.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
Burlington
BURL
$22B
| $725K | ﹤0.01% |
2,751
-260
| -9% | -$67.3K |
|
|
CWAN
927
DELISTED
Clearwater Analytics
CWAN
| $724K | ﹤0.01% |
+28,675
| New | +$645K |
|
928
Roivant Sciences
ROIV
$25.2B
| $724K | ﹤0.01% |
62,720
+1,138
| +2% | +$13K |
|
|
IBTX
929
DELISTED
Independent Bank Group, Inc.
IBTX
| $724K | ﹤0.01% |
12,552
+1,793
| +17% | +$98K |
|
930
Synaptics
SYNA
$4.41B
| $719K | ﹤0.01% |
9,265
-5,395
| -37% | -$433K |
|
931
Axos Financial
AX
$5.45B
| $716K | ﹤0.01% |
11,391
+3,044
| +36% | +$200K |
|
932
First Bancorp
FBP
$4.4B
| $715K | ﹤0.01% |
33,791
+8,107
| +32% | +$165K |
|
933
Upbound Group
UPBD
$1.19B
| $710K | ﹤0.01% |
22,192
+6,060
| +38% | +$195K |
|
934
Biohaven
BHVN
$2.16B
| $709K | ﹤0.01% |
14,190
+5,026
| +55% | +$196K |
|
935
Jazz Pharmaceuticals
JAZZ
$15.9B
| $706K | ﹤0.01% |
6,340
-525
| -8% | -$57.5K |
|
936
Protagonist Therapeutics
PTGX
$8.75B
| $706K | ﹤0.01% |
15,681
+4,411
| +39% | +$178K |
|
937
Archrock
AROC
$6.33B
| $706K | ﹤0.01% |
34,859
+13,478
| +63% | +$273K |
|
938
Apple Hospitality REIT
APLE
$3.96B
| $705K | ﹤0.01% |
47,482
+14,078
| +42% | +$204K |
|
939
Brinker International
EAT
$8.02B
| $704K | ﹤0.01% |
9,205
+2,438
| +36% | +$168K |
|
940
Xerox
XRX
$337M
| $704K | ﹤0.01% |
67,786
+40,660
| +150% | +$435K |
|
941
Skywest
SKYW
$4.11B
| $704K | ﹤0.01% |
8,275
+2,042
| +33% | +$160K |
|
942
Fidelity National Financial
FNF
$13.9B
| $703K | ﹤0.01% |
11,324
-917
| -7% | -$51.5K |
|
943
Simply Good Foods
SMPL
$904M
| $703K | ﹤0.01% |
20,209
+5,055
| +33% | +$171K |
|
944
PTC Therapeutics
PTCT
$6.37B
| $703K | ﹤0.01% |
18,938
+4,551
| +32% | +$152K |
|
945
BGC Group
BGC
$5.58B
| $700K | ﹤0.01% |
76,283
+20,626
| +37% | +$193K |
|
946
Peabody Energy
BTU
$2.78B
| $700K | ﹤0.01% |
26,380
+9,138
| +53% | +$208K |
|
|
VGR
947
DELISTED
Vector Group Ltd.
VGR
| $698K | ﹤0.01% |
46,811
+24,657
| +111% | +$332K |
|
948
ESCO Technologies
ESE
$8.49B
| $696K | ﹤0.01% |
5,398
+1,452
| +37% | +$171K |
|
949
Guardant Health
GH
$19.5B
| $696K | ﹤0.01% |
30,326
+6,885
| +29% | +$195K |
|
950
MGE Energy Inc
MGEE
$3.11B
| $695K | ﹤0.01% |
7,601
+1,988
| +35% | +$170K |
|
Similar funds
ProShare Advisors's Q3 2024 Portfolio in Review
As of Q3 2024, ProShare Advisors held 2,151 positions worth $40.8B, up 9.2% from $37.4B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
ProShare Advisors's Q3 2024 filing shows 303 new, 1,108 increased, 653 reduced and 86 closed positions. Its largest new stake was NexPoint Residential Trust: 319,514 shares worth $14.1M. The largest sale was Qualcomm, an estimated $230M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 31% a quarter earlier, followed by Consumer Staples and Industrials.
- ProShare Advisors's largest Q3 2024 buy was NexPoint Residential Trust: 319,514 shares worth $14.1M.
- ProShare Advisors added most to West Pharmaceutical in Q3 2024, an estimated $197M increase.
- ProShare Advisors's biggest Q3 2024 reduction was Qualcomm, cutting an estimated $230M.
- ProShare Advisors fully exited Atrion Corp in Q3 2024, selling an estimated $8.02M.
- ProShare Advisors's ten largest holdings make up 25% of its $40.8B portfolio in Q3 2024.
- ProShare Advisors opened 303 new positions and closed 86 in Q3 2024.
- ProShare Advisors's portfolio value rose 9.2% quarter-over-quarter to $40.8B.
Based on ProShare Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.